{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:03:31Z","timestamp":1789351411237,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cost Eff Resour Alloc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extended Cost-Effectiveness Analysis (ECEA) extends conventional cost-effectiveness analysis by incorporating financial risk protection (FRP) and examining the distribution of health and economic outcomes across socioeconomic groups. This scoping review aimed to map the application of ECEA in health-sector studies, identify methodological patterns, and explore geographic and thematic research gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted in accordance with PRISMA 2020 guidelines. Searches were performed on 29 October 2025 in PubMed, Scopus, Web of Science, ProQuest, and Google Scholar. Studies published between 2000 and 2025 that applied ECEA to evaluate health interventions were eligible for inclusion. Data were extracted on intervention characteristics, analytical approaches, equity measures, and FRP outcomes and were synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,955 records were identified, of which 19 studies met the inclusion criteria. Most studies were conducted in low- and middle-income countries, particularly in Asia and Africa. The included studies primarily evaluated vaccination programs, taxation policies on harmful products, publicly financed health services, and maternal and child health interventions. Financial Risk Protection (FRP) outcomes were most commonly reported as reductions in out-of-pocket expenditures, catastrophic health expenditures averted, and poverty cases averted. Across studies, ECEA was predominantly used to assess the distribution of health and financial outcomes across socioeconomic groups, with outcomes commonly reported by income quintiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ECEA applications remain limited and are predominantly concentrated in low- and middle-income countries, particularly within preventive and fiscal health interventions. The reviewed evidence suggests that ECEA provides a useful framework for assessing both health outcomes and financial risk protection across socioeconomic groups. Future research should expand ECEA applications to underrepresented settings and promote greater methodological standardization of equity and FRP measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12962-026-00791-4","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T20:34:53Z","timestamp":1782678893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended cost-effectiveness analysis in global health systems: a scoping review of geographic gaps and research trends"],"prefix":"10.1186","volume":"24","author":[{"given":"Saman","family":"Najafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Nekoei","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Amiresmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Barouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Haqhdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Jafari","family":"Sirizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4399-3498","authenticated-orcid":false,"given":"Reza","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"issue":"3","key":"791_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/heapol\/czae001","volume":"39","author":"HL Fraser","year":"2024","unstructured":"Fraser HL, Feldhaus I, Edoka IP, Wade AN, Kohli-Lynch CN, Hofman K, et al. Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa. Health Policy Plann. 2024;39(3):253\u201367.","journal-title":"Health Policy Plann"},{"key":"791_CR2","first-page":"3","volume":"274","author":"M Diomidous","year":"2020","unstructured":"Diomidous M, Magdalinou A. Health and Health Determinants. Stud Health Technol Inform. 2020;274:3\u20139.","journal-title":"Stud Health Technol Inform"},{"issue":"3","key":"791_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/phe\/phad017","volume":"16","author":"T Schramme","year":"2023","unstructured":"Schramme T. Health as Complete Well-Being: The WHO Definition and Beyond. Public health ethics. 2023;16(3):210\u20138.","journal-title":"Public health ethics"},{"key":"791_CR4","doi-asserted-by":"crossref","unstructured":"Pl\u00e1cido AI, Herdeiro MT, Roque F. Health and wellbeing in aging. Int J Environ Res Public Health. 2022;19(14).","DOI":"10.3390\/ijerph19148835"},{"key":"791_CR5","doi-asserted-by":"crossref","unstructured":"Pillarisetti A, Jamison DT, Smith KR. Household energy interventions and health and finances in Haryana, India: an extended cost-effectiveness analysis. In: Mock CN, Nugent R, Kobusingye O, Smith KR, editors Injury Prevention and Environmental Health. Washington (DC): The International Bank for Reconstruction and Development \/ The World Bank. \u00a9 2017 International Bank for Reconstruction and Development \/ The World Bank. 2017.","DOI":"10.1596\/978-1-4648-0522-6_ch12"},{"key":"791_CR6","doi-asserted-by":"crossref","unstructured":"Verguet S, Gauvreau CL, Mishra S, MacLennan M, Murphy SM, Brouwer ED, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. In: Hu TW, editor. Economics of Tobacco Control in China: From Policy Research to Practice. Hackensack (NJ): World Scientific Publishing; 2016. p. 215-243.","DOI":"10.1142\/9789813108721_0013"},{"issue":"2","key":"791_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jval.2016.11.027","volume":"20","author":"R Cookson","year":"2017","unstructured":"Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins B, Norheim OF, et al. Using Cost-Effectiveness Analysis to Address Health Equity Concerns. Value health: J Int Soc Pharmacoeconomics Outcomes Res. 2017;20(2):206\u201312.","journal-title":"Value health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"6","key":"791_CR8","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","volume":"3","author":"J Ochalek","year":"2018","unstructured":"Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ global health. 2018;3(6):e000964.","journal-title":"BMJ global health"},{"key":"791_CR9","unstructured":"Watkins DA, Nugent R, Verguet S. Extended cost-effectiveness analyses of cardiovascular risk factor reduction policies. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors Cardiovascular, Respiratory, and Related Disorders. Washington (DC): The International Bank for Reconstruction and Development \/ The World Bank."},{"issue":"4","key":"791_CR10","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S2214-109X(15)70095-1","volume":"3","author":"S Verguet","year":"2015","unstructured":"Verguet S, Gauvreau CL, Mishra S, MacLennan M, Murphy SM, Brouwer ED, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Global health. 2015;3(4):e206\u201316.","journal-title":"Lancet Global health"},{"key":"791_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"791_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement science: IS. 2010;5:69.","journal-title":"Implement science: IS"},{"issue":"1","key":"791_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"3","key":"791_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hec.3019","volume":"24","author":"S Verguet","year":"2015","unstructured":"Verguet S, Laxminarayan R, Jamison DT. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ. 2015;24(3):318\u201332.","journal-title":"Health Econ"},{"issue":"4","key":"791_CR15","doi-asserted-by":"publisher","first-page":"e001317","DOI":"10.1136\/bmjgh-2018-001317","volume":"4","author":"A Saxena","year":"2019","unstructured":"Saxena A, Stacey N, Puech PDR, Mudara C, Hofman K, Verguet S. The distributional impact of taxing sugar-sweetened beverages: findings from an extended cost-effectiveness analysis in South Africa. BMJ global health. 2019;4(4):e001317.","journal-title":"BMJ global health"},{"issue":"24","key":"791_CR16","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1016\/j.vaccine.2015.02.052","volume":"33","author":"CE Levin","year":"2015","unstructured":"Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, et al. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2015;33(24):2830\u201341.","journal-title":"Vaccine"},{"issue":"1","key":"791_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13561-021-00328-w","volume":"11","author":"B Raei","year":"2021","unstructured":"Raei B, Emamgholipour S, Takian A, Yaseri M, Abdoli G, Alizadeh A. Distributional health and financial consequences of increased cigarette tax in Iran: extended cost-effectiveness analysis. Health Econ Rev. 2021;11(1):30.","journal-title":"Health Econ Rev"},{"issue":"2","key":"791_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2471\/BLT.18.219980","volume":"97","author":"A Saxena","year":"2019","unstructured":"Saxena A, Koon AD, Lagrada-Rombaua L, Angeles-Agdeppa I, Johns B, Capanzana M. Modelling the impact of a tax on sweetened beverages in the Philippines: An extended cost\u2013effectiveness analysis. Bull World Health Organ. 2019;97(2):97\u2013107.","journal-title":"Bull World Health Organ"},{"key":"791_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12962-016-0058-z","volume":"14","author":"N Raykar","year":"2016","unstructured":"Raykar N, Nigam A, Chisholm D. An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance. Cost Eff resource allocation: C\/E. 2016;14:9.","journal-title":"Cost Eff resource allocation: C\/E"},{"key":"791_CR20","doi-asserted-by":"crossref","unstructured":"Driessen J, Olson ZD, Jamison DT, Verguet S. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis. Social science & medicine (1982). 2015;139:115\u2009\u2013\u200922.","DOI":"10.1016\/j.socscimed.2015.06.018"},{"key":"791_CR21","doi-asserted-by":"crossref","unstructured":"Pecenka CJ, Johansson KA, Solomon Tessema M, Jamison DT, Verguet S. Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia. BMJ Open. 2015;5(4).","DOI":"10.1136\/bmjopen-2014-006402"},{"issue":"1","key":"791_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12936-020-3103-5","volume":"19","author":"LF Assebe","year":"2020","unstructured":"Assebe LF, Kwete XXJ, Wang D, Liu LR, Norheim OF, Jbaily A, et al. Health gains and financial risk protection afforded by public financing of selected malaria interventions in Ethiopia: an extended cost-effectiveness analysis. Malar J. 2020;19(1):10.","journal-title":"Malar J"},{"key":"791_CR23","doi-asserted-by":"crossref","unstructured":"Enden MR, Tolla MT, Norheim OF. Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia. Social science & medicine (1982). 2021;281:114076.","DOI":"10.1016\/j.socscimed.2021.114076"},{"issue":"4","key":"791_CR24","doi-asserted-by":"publisher","first-page":"E597","DOI":"10.1016\/S2214-109X(23)00056-6","volume":"11","author":"WH Mao","year":"2023","unstructured":"Mao WH, Watkins D, Sabin ML, Huang KTY, Langlois E, Ogundeji Y, et al. Effects of public financing of essential maternal and child health interventions across wealth quintiles in Nigeria: an extended cost-effectiveness analysis. Lancet Glob Health. 2023;11(4):E597\u2013605.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"791_CR25","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S2214-109X(22)00552-6","volume":"11","author":"J Dixit","year":"2023","unstructured":"Dixit J, Prinja S, Jyani G, Bahuguna P, Gupta A, Vijayvergiya R, et al. Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis. Lancet Global health. 2023;11(3):e445\u201355.","journal-title":"Lancet Global health"},{"issue":"1","key":"791_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12939-021-01603-2","volume":"21","author":"B Saenz-de-Miera","year":"2022","unstructured":"Saenz-de-Miera B, Wu DC, Essue BM, Maldonado N, Jha P, Reynales-Shigematsu LM. The distributional effects of tobacco tax increases across regions in Mexico: an extended cost-effectiveness analysis. Int J Equity Health. 2022;21(1):8.","journal-title":"Int J Equity Health"},{"key":"791_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.socscimed.2016.10.020","volume":"170","author":"N Salti","year":"2016","unstructured":"Salti N, Brouwer E, Verguet S. The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon. Soc Sci Med. 2016;170:161\u20139.","journal-title":"Soc Sci Med"}],"container-title":["Cost Effectiveness and Resource Allocation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12962-026-00791-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-026-00791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-026-00791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:36:32Z","timestamp":1789349792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12962-026-00791-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1186\/s12962-026-00791-4","relation":{},"ISSN":["1478-7547"],"issn-type":[{"value":"1478-7547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical Approval Received This study was approved by the Ethics Committee of Kerman University of Medical Sciences (Approval Number: IR.KMU.REC.1403.518).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study does not include any individual participant data requiring consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}